Sleep Medicine Reviews最新文献

{"title":"Prevalence of poor sleep quality among stroke survivors: A meta-analysis and systematic review","authors":"Yue-Ying Wang ,&nbsp;Jia-Xin Li ,&nbsp;Yu-Fei Liu ,&nbsp;Wei Bai ,&nbsp;He-Li Sun ,&nbsp;Tong Leong Si ,&nbsp;Zhaohui Su ,&nbsp;Teris Cheung ,&nbsp;Gabor S. Ungvari ,&nbsp;Chee H. Ng ,&nbsp;Qinge Zhang ,&nbsp;Yu-Tao Xiang","doi":"10.1016/j.smrv.2025.102070","DOIUrl":"10.1016/j.smrv.2025.102070","url":null,"abstract":"<div><h3>Background</h3><div>Poor sleep quality is common among stroke survivors, but the prevalence rates vary between studies. This meta-analysis examined the global prevalence of poor sleep quality and its moderating factors among stroke survivors.</div></div><div><h3>Method</h3><div>Relevant publications were systematically searched in PubMed, Web of Science, Embase, PsycINFO, CNKI and WanFang. The pooled prevalence of poor sleep quality and the sleep quality component scores with 95 % confidence intervals (CIs) were calculated using a random-effects model.</div></div><div><h3>Result</h3><div>Totally, 68 studies comprising 14,845 participants who fulfilled study entry criteria were included for analyses. All included studies used the Pittsburgh sleep quality index (PSQI) to assess sleep quality. The global prevalence of poor sleep quality in stroke survivors was 50.26 % (95%CI: 46.69%–53.82 %). Stroke location in left hemisphere was associated with a lower risk of poor sleep quality, while stroke type (i.e., cerebral infarction) and lower-middle-income countries were associated with higher risk of poor sleep quality in stroke survivors.</div></div><div><h3>Conclusion</h3><div>In this meta-analysis, poor sleep quality was common among stroke survivors and was moderated by stroke location, type, and countries income. To address the adverse impacts of poor sleep quality in stroke survivors, regular screening and appropriate intervention should be provided in a timely fashion.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102070"},"PeriodicalIF":11.2,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143445480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The impact of pharmacotherapy for premenstrual dysphoric disorder on sleep","authors":"Elisa M.S. Meth ,&nbsp;Diana A. Nôga ,&nbsp;Manon Dubol ,&nbsp;Pei Xue ,&nbsp;Inger Sundström-Poromaa ,&nbsp;Christian Benedict","doi":"10.1016/j.smrv.2025.102069","DOIUrl":"10.1016/j.smrv.2025.102069","url":null,"abstract":"<div><div>Premenstrual dysphoric disorder (PMDD) affects a subset of women of reproductive age, characterized by severe mood disturbances and physical symptoms during the luteal phase of the menstrual cycle. Symptoms include mood swings, irritability, anxiety, fatigue, physical discomfort, and disruptions to sleep and circadian rhythms, such as altered melatonin secretion. Despite the prevalence of these symptoms, the impact of PMDD treatments on sleep and circadian markers, like melatonin, remains insufficiently understood. This review examines how dysregulated serotonin signaling, disrupted allopregnanolone activity (a neurosteroid derived from progesterone), and aberrant circadian rhythms contribute to PMDD. It also explores the effects of pharmacological treatments, including selective serotonin reuptake inhibitors, on sleep and melatonin regulation, and how these factors influence treatment outcomes. Additionally, the use of hypnotics and sedatives to manage sleep disturbances in PMDD is considered, weighing their potential benefits and risks. A deeper understanding of the interaction between PMDD symptoms, sleep, and circadian rhythms is crucial for developing more effective treatments. Further research is needed to explore the relationship between symptom management, sleep patterns, and circadian function in PMDD, and to determine how these factors can be optimized to improve clinical outcomes and quality of life for women affected by the disorder.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102069"},"PeriodicalIF":11.2,"publicationDate":"2025-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143396227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Corrigendum to “Treatment effect heterogeneity of cognitive behavioral therapy for insomnia – A meta-analysis” [Sleep Medicine Reviews 77 (2024) 101966]","authors":"Lisa Steinmetz ,&nbsp;Laura Simon ,&nbsp;Harald Baumeister ,&nbsp;Kai Spiegelhalder ,&nbsp;Yannik Terhorst","doi":"10.1016/j.smrv.2025.102064","DOIUrl":"10.1016/j.smrv.2025.102064","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102064"},"PeriodicalIF":11.2,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143430221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Response to commentary on “Prevalence of depression in pediatric patients with diagnosed or at high risk for obstructive sleep apnea: A systematic review with meta-analysis”","authors":"","doi":"10.1016/j.smrv.2025.102067","DOIUrl":"10.1016/j.smrv.2025.102067","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102067"},"PeriodicalIF":11.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143378845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Do sleepless nights turn into painful days? Opportunities and challenges in detecting and synthesising the day-to-day sleep-pain relationship","authors":"Nicole K.Y. Tang","doi":"10.1016/j.smrv.2024.102045","DOIUrl":"10.1016/j.smrv.2024.102045","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"79 ","pages":"Article 102045"},"PeriodicalIF":11.2,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142910737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A commentary on the article: \"Treatment effect heterogeneity of cognitive behavioral therapy for insomnia-A meta-analysis\"","authors":"Jialin Wang ,&nbsp;Zhoupeng Lu ,&nbsp;Peng Zhao ,&nbsp;Benxiang He","doi":"10.1016/j.smrv.2025.102063","DOIUrl":"10.1016/j.smrv.2025.102063","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102063"},"PeriodicalIF":11.2,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The dentofacial and upper airway morphology of adults with obstructive sleep apnea: A systematic review and meta-analysis","authors":"Zeyu Wei ,&nbsp;Tingting Zhao ,&nbsp;Yaqi Li ,&nbsp;Peter Ngan ,&nbsp;Zhenhui Wang ,&nbsp;Fang Hua ,&nbsp;Hong He","doi":"10.1016/j.smrv.2025.102065","DOIUrl":"10.1016/j.smrv.2025.102065","url":null,"abstract":"<div><div>The purpose of this systematic review is to summarize evidence regarding the dentofacial and upper airway features of obstructive sleep apnea (OSA) with adults. This systematic review included 32 cross-sectional studies that compared characteristics ascertained from lateral cephalograms or cone beam computed tomography (CBCT) in adults with and without OSA. Comprehensive searches were conducted in PubMed, Embase, and Web of Science from inception to December 2024. Meta-analyses revealed that the inter-first premolar distance (MD = −2.01, P &lt; 0.00001), sella nasion plane length (SN, MD = −2.08, P &lt; 0.00001), posterior airway space (PAS, MD = −1.95, P = 0.03) were notably smaller in the OSA group compared to controls. Conversely, anterior total facial height (ATFH, MD = 2.66, P &lt; 0.0001), the soft palate length (UL, MD = 5.41, P &lt; 0.00001) and the angle constituted by subspinale, nasion and supramentale (ANB, MD = 0.64, P = 0.01) were significantly larger in the OSA group. In comparison to healthy individuals, it is evident that OSA patients may present with a constricted maxillary arch, underdeveloped and clockwise-rotated mandible, augmented vertical facial growth, an inferiorly positioned hyoid bone, and a diminished pharyngeal airway space.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102065"},"PeriodicalIF":11.2,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143095587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cognitive behavioral therapy for insomnia across the spectrum of alcohol use disorder: A systematic review and meta-analysis","authors":"Cagdas Türkmen ,&nbsp;Carlotta L. Schneider ,&nbsp;Wolfgang Viechtbauer ,&nbsp;Ingeborg Bolstad ,&nbsp;Subhajit Chakravorty ,&nbsp;Mary Beth Miller ,&nbsp;Håvard Kallestad ,&nbsp;Guro W. Angenete ,&nbsp;Anna F. Johann ,&nbsp;Bernd Feige ,&nbsp;Kai Spiegelhalder ,&nbsp;Dieter Riemann ,&nbsp;Øystein Vedaa ,&nbsp;Ståle Pallesen ,&nbsp;Elisabeth Hertenstein","doi":"10.1016/j.smrv.2025.102049","DOIUrl":"10.1016/j.smrv.2025.102049","url":null,"abstract":"<div><div>Insomnia is prevalent among patients with alcohol use disorder (AUD), potentially undermining treatment and increasing the risk of relapse. Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for insomnia, but its efficacy is not well-characterized in patients across the spectrum of AUD. The aim of this meta-analysis was to quantify the effectiveness of CBT-I in improving insomnia severity and alcohol-related outcomes in adults with heavy alcohol use and/or varying levels of AUD severity and comorbid insomnia. MEDLINE, Cochrane Library, PsycINFO and ClinicalTrials.gov were systematically searched (up to February 2024) to retrieve randomized controlled trials (RCTs). Multilevel meta-analyses were conducted to estimate mean differences over time in insomnia severity, measured using the Insomnia Severity Index (ISI), as well as in alcohol craving and alcohol-related psychosocial problems between CBT-I and control groups. For the number of heavy-drinking/abstinent days, incidence rate ratios were estimated. Risk of bias was assessed using the Risk of Bias 2 (RoB 2) tool. Eight RCTs encompassing 426 adults (68.78 % men) were included. Compared with control conditions, CBT-I resulted in a large reduction of insomnia severity post-treatment [estimated ISI reduction = <strong>−</strong>5.51, 95% CI (<strong>−</strong>7.13 to −3.90)], which was maintained at 1-to-3-month [7 studies; estimate = −4.39, 95% CI (<strong>−</strong>6.08 to −2.70)], and 6-month follow-up [4 studies; estimate = −4.55, 95% CI (<strong>−</strong>6.77 to −2.33)]. Alcohol-related outcomes were reported less consistently, and no significant differences were found. The included trials were judged to have a low or moderate overall risk of bias for the assessment of all outcomes. CBT-I effectively reduces insomnia severity across the spectrum of AUD, supporting wide implementation in AUD prevention and treatment settings.</div></div><div><h3>PROSPERO registration number</h3><div>CRD42023464612.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102049"},"PeriodicalIF":11.2,"publicationDate":"2025-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"AI-enhanced imagery rehearsal therapy: A novel approach to treating nightmare disorder","authors":"Michal Kahn","doi":"10.1016/j.smrv.2024.102046","DOIUrl":"10.1016/j.smrv.2024.102046","url":null,"abstract":"","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102046"},"PeriodicalIF":11.2,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychopathology and NREM sleep parasomnias: A systematic review","authors":"Tijana Tomic ,&nbsp;Samantha Mombelli ,&nbsp;Stan Oana ,&nbsp;Luigi Ferini-Strambi ,&nbsp;Andrea Raballo ,&nbsp;Mauro Manconi ,&nbsp;Andrea Galbiati ,&nbsp;Anna Castelnovo","doi":"10.1016/j.smrv.2024.102043","DOIUrl":"10.1016/j.smrv.2024.102043","url":null,"abstract":"<div><div>Non-rapid eye movement (NREM) sleep parasomnias are abnormal motor and/or emotional behaviors originating from \"deep\" slow-wave sleep and with a multifactorial origin. The relationship between NREM parasomnias and psychopathology has been a topic of ongoing debate, but a comprehensive and systematic perspective has been lacking. This systematic review, conducted according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA-P) guidelines, aims to fill this gap in the literature.</div><div>Databases including PubMed, Scopus, Embase, and Web of Science were searched from their inception until March 2024. Only studies written in English were included. We selected case-control studies that reported either psychopathological or neurodevelopmental data in NREM sleep parasomnias, or NREM sleep parasomnia data across different mental disorders, across children and adults.</div><div>Our review found that psychopathological and neurodevelopmental issues are common in NREM parasomnias, with a higher prevalence in affected patients compared to non-affected individuals. Additionally, NREM parasomnias are more common among patients with various psychopathological conditions than in the general population. Medications did not significantly bias these results. These findings suggest that psychopathological aspects should become a core focus of research and treatment strategies for NREM parasomnias.</div></div>","PeriodicalId":49513,"journal":{"name":"Sleep Medicine Reviews","volume":"80 ","pages":"Article 102043"},"PeriodicalIF":11.2,"publicationDate":"2024-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142899809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}